Viewing Study NCT05179603


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-02-21 @ 2:54 PM
Study NCT ID: NCT05179603
Status: TERMINATED
Last Update Posted: 2025-12-24
First Post: 2021-12-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Classic Hodgkin Lymphoma View
None Diffuse Large B-cell Lymphoma View
Keywords: